Results 171 to 180 of about 699,373 (191)
Some of the next articles are maybe not open access.
Evaluation of Adjunctive Subconjunctival Injection of Bevacizumab before Pterygium Surgery
The Egyptian Journal of Hospital MedicineBackground: Pterygium is a common ocular surface lesion involves the bulbar conjunctiva's fibrovascular expansion onto the cornea. The exact cause of pterygium remains unclear, however exposure to ultraviolet radiation is recognized as a significant contributing element.
Mohamed, Mahmoud Abdelbadie +2 more
openaire +3 more sources
Cornea, 2011
Recent studies support the use of bevacizumab to treat ocular neovascularization (NV). In this study, we aimed to investigate changes in growth factors and cytokines in human tears after a subconjunctival bevacizumab injection and to evaluate the clinical effects and safety of the drug in ocular surface NV.Bevacizumab (5 mg/0.2 mL) was injected into ...
Jae Hoon, Jeong +3 more
openaire +2 more sources
Recent studies support the use of bevacizumab to treat ocular neovascularization (NV). In this study, we aimed to investigate changes in growth factors and cytokines in human tears after a subconjunctival bevacizumab injection and to evaluate the clinical effects and safety of the drug in ocular surface NV.Bevacizumab (5 mg/0.2 mL) was injected into ...
Jae Hoon, Jeong +3 more
openaire +2 more sources
Journal of American Association for Pediatric Ophthalmology and Strabismus, 2012
Bevacizumab is widely used for several ocular conditions, including age-related macular degeneration, diabetic retinopathy, corneal neovascularization, neovascular glaucoma, and retinopathy of prematurity. We describe a 14-year-old patient with Stevens-Johnson syndrome in whom subconjunctival injection of bevacizumab in one eye caused bilateral ...
Siddharth, Kesarwani +2 more
openaire +2 more sources
Bevacizumab is widely used for several ocular conditions, including age-related macular degeneration, diabetic retinopathy, corneal neovascularization, neovascular glaucoma, and retinopathy of prematurity. We describe a 14-year-old patient with Stevens-Johnson syndrome in whom subconjunctival injection of bevacizumab in one eye caused bilateral ...
Siddharth, Kesarwani +2 more
openaire +2 more sources
Journal of Clinical & Experimental Ophthalmology, 2011
Corneal neovascularization caused by various ocular conditions such as infectious, inflammatory, degenerative, or traumatic diseases of the cornea and the injury of the limbal stem cell barrier. It is often accompanied by corneal scarring, stromal edema, lipid deposition, and inflammation and is associated with significant visual impairment and poor ...
openaire +1 more source
Corneal neovascularization caused by various ocular conditions such as infectious, inflammatory, degenerative, or traumatic diseases of the cornea and the injury of the limbal stem cell barrier. It is often accompanied by corneal scarring, stromal edema, lipid deposition, and inflammation and is associated with significant visual impairment and poor ...
openaire +1 more source
Journal francais d'ophtalmologie, 2016
To evaluate and compare the efficacy of subconjunctival bevacizumab injections alone, photodynamic therapy alone and combined treatments for reduction of corneal neovascularization.This study was conducted as a prospective case series. A total of seven eyes of 7 patients with corneal neovascularization caused by ocular surface disorders including ...
J, Hamdan +4 more
openaire +1 more source
To evaluate and compare the efficacy of subconjunctival bevacizumab injections alone, photodynamic therapy alone and combined treatments for reduction of corneal neovascularization.This study was conducted as a prospective case series. A total of seven eyes of 7 patients with corneal neovascularization caused by ocular surface disorders including ...
J, Hamdan +4 more
openaire +1 more source
Subconjunctival injection of bevacizumab for recurrent conjunctival papilloma: a case report
Canadian Journal of Ophthalmology, 2017Chia-Yi, Lee +4 more
openaire +2 more sources
Subconjunctival bevacizumab for corneal neovascularization
Acta Ophthalmologica, 2010Samar Farid
exaly